FS Development Corp. II
Status: Closed Deal
U=S
| IPO Proceeds, $M | $201.25M |
|---|---|
| IPO Date | Feb 17, 2021 |
| CEO | Jim Tananbaum |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Pardes Biosciences |
| Deal Announced | Jun 29, 2021 |
| Deal Size, $M | $339.20M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 23, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 23, 2021 |
Formerly FSII
PRDS
| Price | 2.13 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.